In addition, the observation that one biological mechanism (elevated ghrelin) may contribute to multiple co-morbid mental disorders suggests that a single strategy (reducing circulating acyl-ghrelin) could have a multi-faceted therapeutic benefit. This evidence concerns the gene GHRL and mental disorder.